日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

RETRACTED: Refolo et al. Chlorogenic Acid Improves the Regorafenib Effects in Human Hepatocellular Carcinoma Cells. Int. J. Mol. Sci. 2018, 19, 1518

撤稿:Refolo 等人,《绿原酸增强瑞戈非尼对人肝癌细胞的作用》,《国际分子科学杂志》,2018,19,1518

Refolo, Maria Grazia; Lippolis, Catia; Carella, Nicola; Cavallini, Aldo; Messa, Caterina; D'Alessandro, Rosalba

CC48 a new CB2R agonist/FAAH inhibitor dual drug blocks gastric cancer progression and overcomes paclitaxel resistance.

CC48 是一种新型 CB2R 激动剂/FAAH 抑制剂双效药物,可阻断胃癌进展并克服紫杉醇耐药性

Schirizzi Annalisa, Renna Natasha, De Leonardis Giampiero, Montanaro Rosangela, Mastropasqua Francesco, Graziano Giovanni, Riganti Chiara, Pisano Isabella, Laghezza Antonio, Abate Carmen, Stefanachi Angela, Colabufo Nicola Antonio, Caccioppoli Cristina, Bianco Giusy, Valentini Anna Maria, Armentano Raffaele, Giannelli Gianluigi, Contino Marialessandra, D'Alessandro Rosalba

Unravelling Paclitaxel Resistance in Gastric Cancer: The Role of Small Extracellular Vesicles in Epithelial Mesenchymal Transition and Extracellular Matrix Remodelling

揭示胃癌中紫杉醇耐药的机制:小细胞外囊泡在上皮间质转化和细胞外基质重塑中的作用

Panzetta, Giorgia; Schirizzi, Annalisa; Balestra, Francesco; De Luca, Maria; Depalo, Nicoletta; Rizzi, Federica; Ricci, Angela Dalia; De Leonardis, Giampiero; Lotesoriere, Claudio; Giannelli, Gianluigi; D'Alessandro, Rosalba; Scavo, Maria Principia

Circulating miR-23b-3p, miR-30e-3p, and miR-205-5p as Novel Predictive Biomarkers for Ramucirumab-Paclitaxel Therapy Outcomes in Advanced Gastric Cancer

循环 miR-23b-3p、miR-30e-3p 和 miR-205-5p 作为晚期胃癌雷莫芦单抗联合紫杉醇治疗疗效的新型预测生物标志物

Piccinno, Emanuele; Schirizzi, Annalisa; Scalavino, Viviana; De Leonardis, Giampiero; Donghia, Rossella; Fantasia, Alessia; Ricci, Angela Dalia; Lotesoriere, Claudio; Giannelli, Gianluigi; Serino, Grazia; D'Alessandro, Rosalba

Autotaxin-Lysophosphatidate Axis: Promoter of Cancer Development and Possible Therapeutic Implications

自泌素-溶血磷脂酸轴:癌症发展的促进因素及其潜在的治疗意义

Laface, Carmelo; Ricci, Angela Dalia; Vallarelli, Simona; Ostuni, Carmela; Rizzo, Alessandro; Ambrogio, Francesca; Centonze, Matteo; Schirizzi, Annalisa; De Leonardis, Giampiero; D'Alessandro, Rosalba; Lotesoriere, Claudio; Giannelli, Gianluigi

Tumor Immune Microenvironment in Intrahepatic Cholangiocarcinoma: Regulatory Mechanisms, Functions, and Therapeutic Implications

肝内胆管癌的肿瘤免疫微环境:调控机制、功能和治疗意义

Ricci, Angela Dalia; Rizzo, Alessandro; Schirizzi, Annalisa; D'Alessandro, Rosalba; Frega, Giorgio; Brandi, Giovanni; Shahini, Endrit; Cozzolongo, Raffaele; Lotesoriere, Claudio; Giannelli, Gianluigi

Targeting Angiogenesis in the Era of Biliary Tract Cancer Immunotherapy: Biological Rationale, Clinical Implications, and Future Research Avenues

胆道癌免疫治疗时代靶向血管生成:生物学原理、临床意义及未来研究方向

Schirizzi, Annalisa; De Leonardis, Giampiero; Lorusso, Vincenza; Donghia, Rossella; Rizzo, Alessandro; Vallarelli, Simona; Ostuni, Carmela; Troiani, Laura; Lolli, Ivan Roberto; Giannelli, Gianluigi; Ricci, Angela Dalia; D'Alessandro, Rosalba; Lotesoriere, Claudio

VEGFA Status as a Predictive Marker of Therapy Outcome in Metastatic Gastric Cancer Patients Following Ramucirumab-Based Treatment

VEGFA状态作为转移性胃癌患者接受雷莫芦单抗治疗后疗效的预测标志物

Schirizzi, Annalisa; Arshadi, Aram; Tolomeo, Doron; Schirosi, Laura; Valentini, Anna Maria; De Leonardis, Giampiero; Refolo, Maria Grazia; Donghia, Rossella; Storlazzi, Clelia Tiziana; Zito, Alfredo; Ricci, Angela Dalia; Vallarelli, Simona; Ostuni, Carmela; Bencivenga, Maria; De Manzoni, Giovanni; Messa, Caterina; Armentano, Raffaele; Giannelli, Gianluigi; Lotesoriere, Claudio; D'Alessandro, Rosalba

Corrigendum: Variations in circulating levels of angiopoietin-2 over time are predictive of ramucirumab-paclitaxel therapy outcome in advanced gastric cancer: results of prospective study

更正:血管生成素-2循环水平随时间的变化可预测晚期胃癌患者接受雷莫芦单抗联合紫杉醇治疗的疗效:前瞻性研究结果

D'Alessandro, Rosalba; Refolo, Maria Grazia; Schirizzi, Annalisa; De Leonardis, Giampiero; Donghia, Rossella; Guerra, Vito; Giannelli, Gianluigi; Lolli, Ivan Roberto; Laterza, Maria Maddalena; De Vita, Ferdinando; Messa, Caterina; Lotesoriere, Claudio

The multiple combination of Paclitaxel, Ramucirumab and Elacridar reverses the paclitaxel-mediated resistance in gastric cancer cell lines

紫杉醇、雷莫芦单抗和埃拉克利达的联合用药可逆转胃癌细胞系中紫杉醇介导的耐药性。

Schirizzi, Annalisa; Contino, Marialessandra; Carrieri, Livianna; Riganti, Chiara; De Leonardis, Giampiero; Scavo, Maria Principia; Perrone, Maria Grazia; Miciaccia, Morena; Kopecka, Joanna; Refolo, Maria Grazia; Lotesoriere, Claudio; Depalo, Nicoletta; Rizzi, Federica; Giannelli, Gianluigi; Messa, Caterina; D'Alessandro, Rosalba